Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Shares Outstanding (Weighted Average) (2024 - 2025)

Historic Shares Outstanding (Weighted Average) for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $87.6 million.

  • Kura Oncology's Shares Outstanding (Weighted Average) rose 79.93% to $87.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.6 million, marking a year-over-year increase of 79.93%. This contributed to the annual value of $86.2 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Kura Oncology's Shares Outstanding (Weighted Average) stood at $87.6 million, which was up 79.93% from $87.6 million recorded in Q2 2025.
  • Kura Oncology's 5-year Shares Outstanding (Weighted Average) high stood at $87.6 million for Q3 2025, and its period low was $83.9 million during Q1 2024.